News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Glenmark Pharmaceuticals, Sanofi (France) (SAN.PA) in $345 Million Drug-Licensing Pact


5/3/2010 9:03:11 AM

WSJ -- India's Glenmark Pharmaceuticals Ltd. said Monday it has agreed to license out development and commercialization rights of a painkiller it is developing to France's Sanofi-Aventis S.A.


Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES